92 related articles for article (PubMed ID: 32552088)
1. An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer.
Brönimann S; Pradere B; Karakiewicz P; Abufaraj M; Briganti A; Shariat SF
Expert Rev Mol Diagn; 2020 Aug; 20(8):841-850. PubMed ID: 32552088
[TBL] [Abstract][Full Text] [Related]
2. The Use of Biomarkers in Prostate Cancer Screening and Treatment.
Alford AV; Brito JM; Yadav KK; Yadav SS; Tewari AK; Renzulli J
Rev Urol; 2017; 19(4):221-234. PubMed ID: 29472826
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX.
Bologna E; Ditonno F; Licari LC; Franco A; Manfredi C; Mossack S; Pandolfo SD; De Nunzio C; Simone G; Leonardo C; Franco G
Clin Pract; 2024 Mar; 14(2):508-520. PubMed ID: 38525718
[TBL] [Abstract][Full Text] [Related]
4. The Emperor Has Some Clothes: Emerging Molecular Diagnostics in Post-Lung Transplant Decision-Making.
Calabrese DR; Shaver CM
Am J Respir Crit Care Med; 2024 May; 209(10):1182-1184. PubMed ID: 38387008
[No Abstract] [Full Text] [Related]
5. An up-to-date catalogue of urinary markers for the management of prostate cancer.
Brönimann S; Pradere B; Karakiewicz P; Huebner NA; Briganti A; Shariat SF
Curr Opin Urol; 2020 Sep; 30(5):684-688. PubMed ID: 32701725
[TBL] [Abstract][Full Text] [Related]
6. An overview of biomarkers in the diagnosis and management of prostate cancer.
Uhr A; Glick L; Gomella LG
Can J Urol; 2020 Aug; 27(S3):24-27. PubMed ID: 32875999
[TBL] [Abstract][Full Text] [Related]
7. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Mori K; Abufaraj M; Mostafaei H; Quhal F; Fajkovic H; Remzi M; Karakiewicz PI; Egawa S; Schmidinger M; Shariat SF; Gust KM
Eur Urol; 2021 Jun; 79(6):783-792. PubMed ID: 33172722
[TBL] [Abstract][Full Text] [Related]
8. Modern biomarkers in prostate cancer diagnosis.
Porzycki P; Ciszkowicz E
Cent European J Urol; 2020; 73(3):300-306. PubMed ID: 33133657
[TBL] [Abstract][Full Text] [Related]
9. Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis.
Visser WCH; de Jong H; Melchers WJG; Mulders PFA; Schalken JA
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339117
[TBL] [Abstract][Full Text] [Related]
10. Association Between Oncotype DX Genomic Prostate Score and Adverse Tumor Pathology After Radical Prostatectomy.
Covas Moschovas M; Chew C; Bhat S; Sandri M; Rogers T; Dell'Oglio P; Roof S; Reddy S; Sighinolfi MC; Rocco B; Patel V
Eur Urol Focus; 2022 Mar; 8(2):418-424. PubMed ID: 33757735
[TBL] [Abstract][Full Text] [Related]
11. A review on the role of tissue-based molecular biomarkers for active surveillance.
Banerjee ; Punnen S
World J Urol; 2022 Jan; 40(1):27-34. PubMed ID: 33590277
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
Jairath NK; Dal Pra A; Vince R; Dess RT; Jackson WC; Tosoian JJ; McBride SM; Zhao SG; Berlin A; Mahal BA; Kishan AU; Den RB; Freedland SJ; Salami SS; Kaffenberger SD; Pollack A; Tran P; Mehra R; Morgan TM; Weiner AB; Mohamad O; Carroll PR; Cooperberg MR; Karnes RJ; Nguyen PL; Michalski JM; Tward JD; Feng FY; Schaeffer EM; Spratt DE
Eur Urol; 2021 Mar; 79(3):374-383. PubMed ID: 33293078
[TBL] [Abstract][Full Text] [Related]
13. Convergence of Prognostic Gene Signatures Suggests Underlying Mechanisms of Human Prostate Cancer Progression.
Luca BA; Moulton V; Ellis C; Connell SP; Brewer DS; Cooper CS
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708551
[TBL] [Abstract][Full Text] [Related]
14. Tumour markers in prostate cancer: The post-prostate-specific antigen era.
Garrido MM; Bernardino RM; Marta JC; Holdenrieder S; Guimarães JT
Ann Clin Biochem; 2022 Jan; 59(1):46-58. PubMed ID: 34463154
[TBL] [Abstract][Full Text] [Related]
15. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways.
Lophatananon A; Light A; Burns-Cox N; Maccormick A; John J; Otti V; McGrath J; Archer P; Anning J; McCracken S; Page T; Muir K; Gnanapragasam VJ
J Clin Urol; 2023 Jul; 16(4):264-273. PubMed ID: 37614642
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial Stress and Age Influence Depression and Anxiety-Related Behavior, Drive Tumor Inflammatory Cytokines and Accelerate Prostate Cancer Growth in Mice.
Bellinger DL; Dulcich MS; Molinaro C; Gifford P; Lorton D; Gridley DS; Hartman RE
Front Oncol; 2021; 11():703848. PubMed ID: 34604038
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines.
Othman EM; Bekhit AA; Anany MA; Dandekar T; Ragab HM; Wahid A
Molecules; 2021 May; 26(10):. PubMed ID: 34065773
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Diffusion Kurtosis Imaging and Amide Proton Transfer Imaging in the Diagnosis and Risk Assessment of Prostate Cancer.
Yin H; Wang D; Yan R; Jin X; Hu Y; Zhai Z; Duan J; Zhang J; Wang K; Han D
Front Oncol; 2021; 11():640906. PubMed ID: 33937041
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
